As of 2025-09-17, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -13.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 290.37 mil USD. CLPT's TTM EBITDA according to its financial statements is -21.68 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 22.7x | 21.4x |
| Forward P/E multiples | 22.4x - 22.6x | 22.4x |
| Fair Price | (16.61) - (16.81) | (16.29) |
| Upside | -255.8% - -257.6% | -252.9% |
| Date | EV/EBITDA |
| 2025-09-16 | -13.38 |
| 2025-09-15 | -13.14 |
| 2025-09-12 | -13.17 |
| 2025-09-11 | -13.96 |
| 2025-09-10 | -13.22 |
| 2025-09-09 | -13.77 |
| 2025-09-08 | -13.75 |
| 2025-09-05 | -13.90 |
| 2025-09-04 | -13.94 |
| 2025-09-03 | -12.85 |
| 2025-09-02 | -13.09 |
| 2025-08-29 | -13.17 |
| 2025-08-28 | -13.17 |
| 2025-08-27 | -13.37 |
| 2025-08-26 | -13.37 |
| 2025-08-25 | -13.18 |
| 2025-08-22 | -13.44 |
| 2025-08-21 | -12.84 |
| 2025-08-20 | -13.01 |
| 2025-08-19 | -13.13 |
| 2025-08-18 | -14.13 |
| 2025-08-15 | -14.56 |
| 2025-08-14 | -14.73 |
| 2025-08-13 | -15.04 |
| 2025-08-12 | -13.23 |
| 2025-08-11 | -13.31 |
| 2025-08-08 | -13.60 |
| 2025-08-07 | -13.73 |
| 2025-08-06 | -13.56 |
| 2025-08-05 | -13.22 |
| 2025-08-04 | -13.22 |
| 2025-08-01 | -12.53 |
| 2025-07-31 | -13.05 |
| 2025-07-30 | -13.39 |
| 2025-07-29 | -13.25 |
| 2025-07-28 | -13.80 |
| 2025-07-25 | -14.14 |
| 2025-07-24 | -14.20 |
| 2025-07-23 | -14.60 |
| 2025-07-22 | -14.13 |
| 2025-07-21 | -13.81 |
| 2025-07-18 | -13.88 |
| 2025-07-17 | -14.34 |
| 2025-07-16 | -14.27 |
| 2025-07-15 | -14.03 |
| 2025-07-14 | -14.95 |
| 2025-07-11 | -14.36 |
| 2025-07-10 | -15.10 |
| 2025-07-09 | -15.47 |
| 2025-07-08 | -14.83 |